Lunai Bioworks (LNAI) Capital Expenditures (2014 - 2024)
Lunai Bioworks (LNAI) recorded quarterly Capital Expenditures of $23552.0 in Q2 2024, up 344.88% quarter-over-quarter from $5294.0 in Q1 2024, and up 283.52% on a YoY basis from $6141.0 in Q3 2023.
Lunai Bioworks (LNAI) Capital Expenditures (2014 - 2024) Analysis & Trends
Lunai Bioworks' Capital Expenditures history runs 7 years deep, the most recent figure standing at $23552.0 for Q2 2024.
- In Q2 2024, Capital Expenditures rose 283.52% year-over-year to $23552.0; the TTM figure through Mar 2026 stood at $34987.0 (changed N/A YoY), while the FY2024 annual figure was $70430.0, up 136.55% from the prior year.
- Capital Expenditures was $23552.0 for Q2 2024 at Lunai Bioworks, up from $5294.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $41694.0 in Q1 2020 to a low of $5156.0 in Q3 2021.
- Historically, Capital Expenditures has averaged $17647.1 across 4 years, with a median of $10584.5 in 2020.
- The sharpest annual moves came in 2020 and 2024: Capital Expenditures tumbled 83.17% in 2020, then surged 283.52% in 2024.
- A 4-year view of Capital Expenditures shows it stood at $10721.0 in 2020, then plunged by 51.91% to $5156.0 in 2021, then advanced by 19.1% to $6141.0 in 2023, then soared by 283.52% to $23552.0 in 2024.
- The last three Capital Expenditures figures came in at $23552.0 (Q2 2024), $5294.0 (Q1 2024), and $6141.0 (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | Lunai Bioworks | 95.85 Mn | 92.70 Mn | 20,942.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 23,552.00 |
| Jun 30, 2024 | 23,552.00 |
| Mar 31, 2024 | 5,294.00 |
| Mar 31, 2024 | 5,294.00 |
| Jun 30, 2023 | 6,141.00 |
| Jun 30, 2023 | 6,141.00 |
| Sep 30, 2021 | 5,156.00 |
| Sep 30, 2021 | 5,156.00 |
| Jun 30, 2021 | 38,171.00 |
| Jun 30, 2021 | 38,171.00 |
| Dec 31, 2020 | 10,721.00 |
| Dec 31, 2020 | 10,721.00 |
| Jun 30, 2020 | 10,448.00 |
| Jun 30, 2020 | 10,448.00 |
| Mar 31, 2020 | 41,694.00 |
| Mar 31, 2020 | 41,694.00 |
| Dec 31, 2019 | 63,705.00 |
| Dec 31, 2019 | 63,705.00 |
| Sep 30, 2019 | 68,616.00 |
| Sep 30, 2019 | 68,616.00 |